-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Lineage Cell Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2014 to 2024.
- Lineage Cell Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 200M shares, a 15.9% increase year-over-year.
- Lineage Cell Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 200M shares, a 15.9% increase from 2023.
- Lineage Cell Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 173M shares, a 1.69% increase from 2022.
- Lineage Cell Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 170M shares, a 3.22% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)